ZA200807828B - Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma - Google Patents
Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucomaInfo
- Publication number
- ZA200807828B ZA200807828B ZA200807828A ZA200807828A ZA200807828B ZA 200807828 B ZA200807828 B ZA 200807828B ZA 200807828 A ZA200807828 A ZA 200807828A ZA 200807828 A ZA200807828 A ZA 200807828A ZA 200807828 B ZA200807828 B ZA 200807828B
- Authority
- ZA
- South Africa
- Prior art keywords
- glaucoma
- treatment
- ocular hypertension
- hypertension control
- prenyltransferase inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78797106P | 2006-03-31 | 2006-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200807828B true ZA200807828B (en) | 2009-11-25 |
Family
ID=38230203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200807828A ZA200807828B (en) | 2006-03-31 | 2007-03-28 | Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma |
Country Status (14)
Country | Link |
---|---|
US (3) | US20070232675A1 (xx) |
EP (1) | EP2001457A1 (xx) |
JP (1) | JP2009532377A (xx) |
KR (1) | KR20080111092A (xx) |
CN (1) | CN101410104A (xx) |
AR (1) | AR060186A1 (xx) |
AU (1) | AU2007234903B2 (xx) |
BR (1) | BRPI0710122A2 (xx) |
CA (1) | CA2645171A1 (xx) |
MX (1) | MX2008012662A (xx) |
RU (1) | RU2008143219A (xx) |
TW (1) | TW200806284A (xx) |
WO (1) | WO2007118009A1 (xx) |
ZA (1) | ZA200807828B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2018323861B2 (en) * | 2017-08-27 | 2023-08-17 | Rhodes Technologies | Pharmaceutical compositions for the treatment of ophthalmic conditions |
US20210008084A1 (en) | 2017-10-16 | 2021-01-14 | Tsinghua University | Mevalonate pathway inhibitor and pharmaceutical composition thereof |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5194429A (en) * | 1988-10-01 | 1993-03-16 | K.K. Ueno Seiyaku Oyo Kenkyujo | Ocular hypotensive agents |
US6083917A (en) * | 1990-04-18 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods and compositions for the identification, characterization and inhibition of farnesyltransferase |
US6627610B1 (en) * | 1992-05-29 | 2003-09-30 | Jeffrey Glenn | Method for inhibition of viral morphogenesis |
US5578477A (en) * | 1993-01-05 | 1996-11-26 | Arch Development Corporation | Identification and characterization of inhibtors of protein farnesyltransferase |
US6100042A (en) * | 1993-03-31 | 2000-08-08 | Cadus Pharmaceutical Corporation | Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
US6011175A (en) * | 1993-05-18 | 2000-01-04 | University Of Pittsburgh | Inhibition of farnesyltransferase |
US5705686A (en) * | 1993-05-18 | 1998-01-06 | University Of Pittsburgh | Inhibition of farnesyl transferase |
US5834434A (en) * | 1993-05-18 | 1998-11-10 | University Of Pittsburgh | Inhibitors of farnesyltransferase |
US5965539A (en) * | 1993-05-18 | 1999-10-12 | Univeristy Of Pittsburgh | Inhibitors of prenyl transferases |
US5602098A (en) * | 1993-05-18 | 1997-02-11 | University Of Pittsburgh | Inhibition of farnesyltransferase |
US5458883A (en) * | 1994-01-12 | 1995-10-17 | Duke University | Method of treating disorders of the eye |
US5789558A (en) * | 1994-01-31 | 1998-08-04 | Merck & Co., Inc. | Protein prenyltransferase |
US5631401A (en) * | 1994-02-09 | 1997-05-20 | Abbott Laboratories | Inhibitors of protein farnesyltransferase and squalene synthase |
US5430055A (en) * | 1994-04-08 | 1995-07-04 | Pfizer Inc. | Inhibitor of squalene synthase |
DK0677513T3 (da) * | 1994-04-15 | 2000-03-27 | Takeda Chemical Industries Ltd | Octahydro-2-naphthalencarboxylsyrederivat, dets fremstilling og anvendelse |
US5571792A (en) * | 1994-06-30 | 1996-11-05 | Warner-Lambert Company | Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
US5571835A (en) * | 1994-09-29 | 1996-11-05 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5585359A (en) * | 1994-09-29 | 1996-12-17 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5831115A (en) * | 1995-04-21 | 1998-11-03 | Abbott Laboratories | Inhibitors of squalene synthase and protein farnesyltransferase |
ATE302613T1 (de) * | 1995-08-09 | 2005-09-15 | Banyu Pharma Co Ltd | Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids |
US6221865B1 (en) * | 1995-11-06 | 2001-04-24 | University Of Pittsburgh | Inhibitors of protein isoprenyl transferases |
US6310095B1 (en) * | 1995-11-06 | 2001-10-30 | University Of Pittsburgh | Inhibitors of protein isoprenyl transferases |
US6204293B1 (en) * | 1995-11-06 | 2001-03-20 | University Of Pittsburgh | Inhibitors of protein isoprenyl transferases |
US6693123B2 (en) * | 1995-11-06 | 2004-02-17 | University Of Pittsburgh | Inhibitors of protein isoprenyl transferases |
WO1998057654A1 (en) * | 1997-06-19 | 1998-12-23 | Johns Hopkins University | Methods for treatment of ocular neovascularization |
US7262338B2 (en) * | 1998-11-13 | 2007-08-28 | Performance Plants, Inc. | Stress tolerance and delayed senescence in plants |
US6423519B1 (en) * | 1998-07-15 | 2002-07-23 | Gpc Biotech Inc. | Compositions and methods for inhibiting fungal growth |
RU2230062C2 (ru) * | 1999-01-21 | 2004-06-10 | Бристол-Маерс Сквибб Ко. | Комплекс ингибитора ras-фарнезилтрансферазы, композиция ингибитора ras-фарнезилтрансферазы, фармацевтическая композиция |
US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6436972B1 (en) * | 2000-04-10 | 2002-08-20 | Dalhousie University | Pyridones and their use as modulators of serine hydrolase enzymes |
US20020019527A1 (en) * | 2000-04-27 | 2002-02-14 | Wei-Bo Wang | Substituted phenyl farnesyltransferase inhibitors |
JP2004509064A (ja) * | 2000-04-27 | 2004-03-25 | アボット・ラボラトリーズ | 置換フェニルファルネシルトランスフェラーゼ阻害剤 |
WO2001089584A2 (en) * | 2000-05-23 | 2001-11-29 | Amersham Health As | Contrast agents |
EP1366183A2 (en) * | 2000-07-06 | 2003-12-03 | The Regents of the University of California | Methods for diagnosis and treatment of psychiatric disorders |
US7211595B2 (en) * | 2000-11-30 | 2007-05-01 | Abbott Laboratories | Farnesyltransferase inhibitors |
US20020115640A1 (en) * | 2000-11-30 | 2002-08-22 | Claiborne Akiyo K. | Farnesyltransferase inhibitors |
US7238514B2 (en) * | 2001-01-05 | 2007-07-03 | William Marsh Rice University | Diterpene-producing unicellular organism |
FR2825278A1 (fr) * | 2001-05-30 | 2002-12-06 | Sod Conseils Rech Applic | Produit comprenant du mikanolide, du dihydromikanolide ou un analogue de ceux-ci en association avec un autre agent anti-cancereux pour une utilisation therapeutique dans le traitement du cancer |
AU2002310441A1 (en) * | 2001-06-14 | 2003-01-02 | The Regents Of The University Of California | A novel signaling pathway for the production of inflammatory pain and neuropathy |
YU44404A (sh) * | 2001-11-23 | 2006-08-17 | Chugai Seiyaku Kabushiki Kaisha | Postupak za identifikovanje ciljnih enzima tumora |
US20030199544A1 (en) * | 2002-04-18 | 2003-10-23 | Woods Keith W. | Farnesyltransferase inhibitors |
US20030199542A1 (en) * | 2002-04-18 | 2003-10-23 | Woods Keith W. | Farnesyltransferase inhibitors |
US20030216441A1 (en) * | 2002-05-10 | 2003-11-20 | Gwaltney Stephen L. | Farnesyltransferase inhibitors |
JP4719572B2 (ja) * | 2003-04-17 | 2011-07-06 | 興和株式会社 | Lklf/klf2遺伝子発現促進剤 |
JP2005073550A (ja) * | 2003-08-29 | 2005-03-24 | Toyota Motor Corp | プレニルアルコールの製造方法 |
JP4691041B2 (ja) * | 2003-11-20 | 2011-06-01 | チルドレンズ ホスピタル メディカル センター | Gtpアーゼ阻害剤および使用方法 |
AU2006239219A1 (en) * | 2005-04-27 | 2006-11-02 | University Of Florida Research Foundation, Inc. | Materials and methods for enhanced degradation of mutant proteins associated with human disease |
-
2007
- 2007-03-27 TW TW096110518A patent/TW200806284A/zh unknown
- 2007-03-28 AR ARP070101305A patent/AR060186A1/es not_active Application Discontinuation
- 2007-03-28 KR KR1020087025925A patent/KR20080111092A/ko not_active Application Discontinuation
- 2007-03-28 JP JP2009503235A patent/JP2009532377A/ja active Pending
- 2007-03-28 EP EP07759550A patent/EP2001457A1/en not_active Withdrawn
- 2007-03-28 MX MX2008012662A patent/MX2008012662A/es not_active Application Discontinuation
- 2007-03-28 ZA ZA200807828A patent/ZA200807828B/xx unknown
- 2007-03-28 WO PCT/US2007/065334 patent/WO2007118009A1/en active Application Filing
- 2007-03-28 BR BRPI0710122-8A patent/BRPI0710122A2/pt not_active IP Right Cessation
- 2007-03-28 AU AU2007234903A patent/AU2007234903B2/en not_active Ceased
- 2007-03-28 CN CNA2007800107454A patent/CN101410104A/zh active Pending
- 2007-03-28 RU RU2008143219/14A patent/RU2008143219A/ru unknown
- 2007-03-28 US US11/692,316 patent/US20070232675A1/en not_active Abandoned
- 2007-03-28 CA CA002645171A patent/CA2645171A1/en not_active Abandoned
-
2009
- 2009-11-06 US US12/614,104 patent/US20100120851A1/en not_active Abandoned
-
2012
- 2012-01-05 US US13/344,258 patent/US20120108632A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20080111092A (ko) | 2008-12-22 |
US20100120851A1 (en) | 2010-05-13 |
WO2007118009A1 (en) | 2007-10-18 |
RU2008143219A (ru) | 2010-05-10 |
US20120108632A1 (en) | 2012-05-03 |
TW200806284A (en) | 2008-02-01 |
JP2009532377A (ja) | 2009-09-10 |
MX2008012662A (es) | 2008-10-13 |
BRPI0710122A2 (pt) | 2011-08-02 |
AU2007234903B2 (en) | 2012-03-01 |
CN101410104A (zh) | 2009-04-15 |
AR060186A1 (es) | 2008-05-28 |
US20070232675A1 (en) | 2007-10-04 |
EP2001457A1 (en) | 2008-12-17 |
CA2645171A1 (en) | 2007-10-18 |
AU2007234903A1 (en) | 2007-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL186598A0 (en) | Composition and method for the treatment or prevention of glaucoma and ocular hypertension | |
EP2083862A4 (en) | COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES AND DISORDERS | |
ZA200704932B (en) | Rnai inhibition of CTGF for treatment of ocular disorders | |
EP1893216A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES | |
PT2374472T (pt) | Composições e métodos para o tratamento de afeções oftalmológicas | |
IL197933A0 (en) | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases | |
IL191283A (en) | Compositions for treating eye irregularities | |
EP2063897A4 (en) | KINASEHEMMER FOR THE TREATMENT OF PROLIFERATIVE DISEASES | |
EP2063896A4 (en) | KINASEHEMMER FOR THE TREATMENT OF PROLIFERATIVE DISEASES | |
EP1981526A4 (en) | ADIPONECTIN FOR THE TREATMENT OF VARIOUS DISORDERS | |
IL197118A0 (en) | Ultrasonic treatment of glaucoma | |
PL2056863T3 (pl) | Leczenie chorób oczu | |
AU2007208516A8 (en) | Combination of ache inhibitor and 5-HT6 antagonist for the treatment of cognitive dysfunction | |
IL207397A0 (en) | Difluorobiphenylamide derivtives for the treatment of ocular hypertension | |
HK1247943A1 (zh) | 發育相關疾病的治療 | |
PT2056804E (pt) | Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de doenças oculares | |
EP2069391A4 (en) | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING EYE DRYING | |
GB0909297D0 (en) | Composition for the treatment of skin conditions | |
EP2077838A4 (en) | METHODS FOR TREATING A-RELATED DISORDERS AND COMPOSITIONS THEREFOR | |
IL198941A0 (en) | Isosorbide mononitrate derivatives for the treatment of ocular hypertension | |
EP1988889A4 (en) | COMPOSITIONS AND METHODS OF TREATMENT FOR OPHTHALMIC DISEASES AND DISORDERS | |
IL188787A (en) | Preparations for the treatment of diabetic eye complications | |
IL193799A0 (en) | New therapeutic combinations for the treatment or prevention of psycotic disorders | |
EP2032130A4 (en) | OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF EYE HIGH PRESSURE | |
IL192933A0 (en) | Benzoisoindole derivatives for the treatment of pain |